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TennesseeABSTRACT Interactions of the hydrophobic anticancer drug tamoxifen (TAM) with lipid model membranes were studied using
calcein-encapsulated vesicle leakage, attenuated total reflection Fourier transform infrared (FTIR) spectroscopy, small-angle
neutron scattering (SANS), atomic force microscopy (AFM) based force spectroscopy, and all-atom molecular dynamics
(MD) simulations. The addition of TAM enhances membrane permeability, inducing calcein to translocate from the interior to
the exterior of lipid vesicles. A large decrease in the FTIR absorption band’s magnitude was observed in the hydrocarbon chain
region, suggesting suppressed bond vibrational dynamics. Bilayer thickening was determined from SANS data. Force spectros-
copy measurements indicate that the lipid bilayer area compressibility modulus KA is increased by a large amount after the incor-
poration of TAM. MD simulations show that TAM decreases the lipid area and increases chain order parameters. Moreover,
orientational and positional analyses show that TAM exhibits a highly dynamic conformation within the lipid bilayer. Our detailed
experimental and computational studies of TAM interacting with model lipid membranes shed new light on membrane modula-
tion by TAM.INTRODUCTIONTamoxifen (TAM) is an important anticancer drug that is
commonly used in the prevention and treatment of breast
cancer (1), and also exhibits antioxidant and cardioprotec-
tive effects (2). One mechanism by which TAM inhibits can-
cer cell growth is competitive blocking of estrogen receptors
(3). However, TAM also inhibits the growth of estrogen-re-
ceptor-negative breast cancer cells (4). This implies the
presence of additional mechanisms that are not related to es-
trogen receptor mediation. TAM was also found to antago-
nize protein kinase C without interacting with the
enzyme’s active site (5). Other studies have shown that
TAM can cause liver toxicity by affecting mitochondria
functions (6). Since TAM is highly lipophilic (7), modula-
tion of cell membrane structural and mechanical properties
may be a reason for its anticancer activity (2) and associated
adverse effects (8).
Model lipid bilayers composed of one or a few lipid spe-
cies are suitable systems for investigating the interactions of
membrane active compounds with cell membranes. Previ-
ous studies of TAM and lipid bilayers mainly used fluores-
cence anisotropy, differential scanning calorimetry (DSC),
and Fourier transform infrared (FTIR) spectroscopy. In
particular, anisotropy and DSC measurements have shown
that TAM decreases lipid-phase transition temperatures
(9–14). Studies using anisotropy (9) and FTIR (15) mea-Submitted September 5, 2014, and accepted for publication April 14, 2015.
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organization, although another study found no discernible
anisotropy change (11). Other studies using FTIR have
reported mixed effects on gel-phase chain packing as a
function of TAM concentration (12–14,16). Similar discrep-
ancies have been reported for fluid-phase lipid chain organi-
zation. Chain ordering (9,11,15,17), disordering (10,18,19),
and concentration-dependent effects (12–14,16) have all
been reported using anisotropy and FTIR measurements
(on saturated phospholipids). These mixed reports are
complicated by the fact that both fluorescence anisotropy
and FTIR are not very sensitive to small changes in lipid
bilayer properties. For example, we observed no band shift
in our FTIR spectra, whereas our other techniques clearly
showed membrane modulation exerted by TAM (see Results
section). Similarly, we have unpublished data showing that
fluorescence anisotropy is not a sensitive technique when
only small changes take place in a fluid phase bilayer. More-
over, fluorescence anisotropy relies on membrane-solubi-
lized dye molecules, which can modify lipid bilayer
properties (20). Finally, many of the above-mentioned
studies used bilayers composed of lipids with two saturated
chains, mainly because this facilitates access to the gel and
fluid phases. Although these lipids are experimentally
appealing, lipids with one saturated and one unsaturated
chain are better mimics of biological membranes.
Here, we examined the effects of TAM on a lipid bilayer
composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphati-
dylcholine (POPC). Since biological membranes oftenhttp://dx.doi.org/10.1016/j.bpj.2015.04.010
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toyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol (POPG) to
the POPC bilayer. For simplicity, we will refer to this
mixture as a POPC/POPG bilayer. We first used a fluores-
cence leakage assay to elucidate the perturbation effect of
TAM on POPC/POPG bilayer integrity. We also used atten-
uated total reflection FTIR spectroscopy to explore lipid
bond vibrational dynamics (21). Due to the differences in
neutron scattering length between the lipid bilayer’s hydro-
carbon chains and the D2O solvent, small-angle neutron
scattering (SANS) is widely used to determine the lipid
bilayer hydrophobic thickness, as well as other important
structural parameters (22). We collected SANS data under
three external contrast conditions for POPC/POPG bilayers,
with and without TAM, and determined measurable changes
in the lipid bilayer thickness. We investigated the effects of
TAM on lipid bilayer mechanical properties using atomic
force microscopy (AFM)-based force spectroscopy mea-
surements. We then used the force-distance curves obtained
as the AFM tip approached a solid supported planar bilayer
with different TAM concentrations to extract the lipid
bilayer area compressibility moduli KA. Finally, we per-
formed all-atom molecular dynamics (MD) simulations to
gain a mechanistic understanding of TAM interactions
with neighboring lipids. We carried out detailed analyses
pertaining to TAM orientation and its impact on lipid bilayer
properties, such as the average lipid area, hydrocarbon chain
thickness, and chain order parameters.MATERIALS AND METHODS
Materials
Synthetic POPC and POPG, in powder form, were purchased from Avanti
Polar Lipids (Alabaster, AL). TAM and calcein were purchased from Sigma
Aldrich (St. Louis, MO). All other chemicals were of HPLC grade.
POPC, POPG, and TAM stock solutions were prepared using organic sol-
vents (chloroform for POPC and TAM, and chloroform/methanol 3:1 by
volume for POPG). Lipid mixtures were prepared by mixing appropriate ra-
tios of stock solutions in glass test tubes. Organic solvents were removed by
a gentle stream of argon gas and then placed under vacuum overnight. The
resultant lipid dry films were used for experimental measurements.Dye leakage
Calcein-encapsulated unilamellar vesicles (ULVs) were prepared using the
method described in the Supporting Material. Fluorescence intensity at
25C was measured using an FP-8300 fluorometer (Jasco, Easton, MD).
To study the degree of dye leakage as a function of the TAM/lipid ratio,
r, we added different amounts of TAM solubilized in DMSO to microcen-
trifuge tubes containing 1 ml of HEPES buffer B (SupportingMaterial), and
added 15 ml of calcein-encapsulated ULVs at the end. To assess the effect of
DMSO on calcein leakage, we performed control experiments with DMSO
alone. No discernible dye leakage was observed for DMSO concentrations
of <3%. Based on these data, all calcein leakage experiments were carried
out with <1.5% of DMSO.
A time-course measurement was first carried out to establish the equili-
bration time needed for TAM to induce maximum calcein leakage
(Fig. S13). TAM caused a rapid increase in fluorescence intensity duringthe first 9 min, followed by a gradual increase. The final equilibrium state
was reached in ~8 h. To eliminate complications associated with incubation
time, all TAM/lipid samples were measured after they were incubated over-
night in the dark under gentle shaking.
After incubation, TAM/lipid/calcein solutions were excited by a wave-
length of 494 nm. The emission spectrum was recorded from 498 nm to
600 nm. Both the excitation and emission bandwidths were 2.5 nm. The
emission maximum near 514 nm was taken as the fluorescence intensity I
for each sample. The fluorescence intensity without any quenching, Imax,
was determined by completely breaking up the ULVs using 100 mM Triton
X-100 (after taking dilution into account). The percentage of calcein
leakage is defined as
G ¼ ðI  I0Þ=ðImax  I0Þ  100%; (1)
where I0 is the fluorescence intensity from calcein-encapsulated ULVs
without TAM.FTIR spectroscopy
AVertex 70 Bio ATRII spectrometer (Bruker, Billerica, MA) was used for
attenuated total reflection FTIR measurements. All samples were main-
tained at 25C using a Huber Ministat water circulator. POPC lipid
(8.0 mg) mixed with different amounts of TAM was hydrated with
0.25 ml of HEPES buffer A (Supporting Material). A multilamellar vesicle
(MLV) solution (30 ml) was loaded into a sample cell. Infrared (IR) absorp-
tion spectra were collected at a range of wavenumbers from 400 to
4000 cm1 with a resolution of 2 cm1 (1500 scans). Each spectrum was
corrected for background absorption arising from the water buffer. The final
spectrum was normalized by the lipid concentration.SANS experiments
Lipid dry films, with and without 10 mol % TAM, were hydrated with D2O
buffer. ULVs were obtained by an extrusion procedure similar to that used
for the leakage experiments. The extruded ULVs in 100% D2O were ali-
quoted into three microcentrifuge tubes and diluted to the desired external
contrast conditions (i.e., 100%, 75%, and 50% D2O) using appropriate ra-
tios of D2O and H2O buffers. SANS data were obtained at 25
C on the
CG-3 Bio-SANS instrument located at Oak Ridge National Laboratory
(ORNL). The beam wavelength was 6.0 A˚ with a dispersion of 12%. The
collected scattering images were corrected for dark current, solid angle, de-
tector sensitivity, and sample transmission. One-dimensional scattering
curves were obtained by powder averaging after correcting for water back-
ground. All data reduction was performed using the Mantid software pro-
vided by ORNL (http://dx.doi.org/10.5286/SOFTWARE/MANTID).AFM experiments
AFM experiments were performed using a Multimode 8 atomic force mi-
croscope (Bruker, Santa Barbara, CA) operated in a mode referred to as
PeakForce quantitative nanomechanics (QNM). This mode allows simulta-
neous mapping of a sample’s nanomechnical and topographical properties.
Small unilamellar vesicles (SUVs) were used for AFM measurements.
Briefly, lipid films with different TAM concentrations were hydrated with
10 mM of HEPES buffer. SUVs were prepared using an ultrasonicator oper-
ated at 40 W for a total duration of 15 min. The obtained SUVs were centri-
fuged to remove metal particles that detached from the probe. Dynamic
light scattering measurements showed that the ultrasonication-prepared
SUVs had an average diameter of 60 nm. The SUVs were injected into a
liquid cell via a syringe pump. After incubation for 1 h, a mica supported
bilayer was formed. HEPES buffer was injected to flush out excess vesicles.
We scanned hydrated bilayers using a Si3N4 cantilever with a spring con-
stant of 0.1 N/m, which was determined using the thermal noise method
(23). After obtaining a topographic image, we collected multipleBiophysical Journal 108(10) 2492–2501
2494 Khadka et al.force-distance curves at different locations on the bilayer. To extract the
lipid bilayer area compressibility modulus, we determined the AFM tip
radius using a tip-quantification function provided by the Nanoscope anal-
ysis software. The tip radius determined for this study was 11.0 nm.FIGURE 1 Leakage of calcein-encapsulated ULVs induced by TAM.
The solid line is a fit using the empirical Hill equation. To see this figure
in color, go online.MD simulations
We generated the initial coordinates for two POPC/POPG bilayer models
made up of 200 lipids (i.e., 180 POPC and 20 POPG) using the
CHARMM-GUI Membrane Builder (24) for one model and Packmol
(25) for the other. Despite their different initial structural properties, the
two model bilayers yielded similar results, with comparable average lipid
area and chain thickness (after reaching equilibrium). This highlights that
our simulations do not depend on initial conditions, thus supporting the
convergence of our simulated bilayers. We generated the initial coordinates
for the two POPC/POPG/TAM lipid bilayer systems (i.e., 162 POPC, 18
POPG, and 20 TAM) using Packmol with different random seeds and pack-
ing protocols. All hydrogen atoms were explicitly included (all-atom
model) in addition to ~10,800 water molecules and counterions to
neutralize the system. MD simulations were performed using NAMD 2.9
(26) and the CHARMM 36 lipid force field (27,28) for lipid molecules,
and the CHARMM general force field for TAM was generated using the
ParamChem server (http://www.paramchem.org) (29). Periodic boundary
conditions were applied. For each system, we first minimized the atomic co-
ordinates using the conjugated gradient algorithm for 5000 steps, followed
by 20 ns of equilibration in a constant particle NPT ensemble. The z axis
was allowed to expand and contract independently of the x-y plane (semi-
isotropic pressure coupling). Subsequently, the four simulations (two
POPC/POPG binary mixtures and two POPC/POPG mixed with 10 mol
% TAM) were each run for ~150 ns in the NPT ensemble using the Lange-
vin piston method (target pressure: 1 atm; oscillation period: 200 fs; and
damping timescale: 100 fs) and Langevin dynamics to control the temper-
ature (298 K; damping coefficient: 2.0) during the entire simulation (30,31).
In all simulations, the van der Waals (vdW) interactions were truncated via
a force-based switching function. Starting from a switching distance of 8 A˚,
the vdW force was brought smoothly to zero at the cutoff distance of 12 A˚.
Electrostatic interactions were treated using the particle-mesh Ewald
(PME) method with a 1.0 A˚ grid spacing (32,33). The r-RESPA multiple-
time-step method (34) was employed with a 2 fs time step for bonded inter-
actions, and 2 and 4 fs time steps for short-range nonbonded and long-range
electrostatic interactions, respectively. The bonds between hydrogen and
other atoms were constrained using the SHAKE algorithm (35). All simu-
lations were conducted on the Hopper supercomputer located at the
National Energy Research Scientific Computing Center (NERSC).
Only the last 100 ns of all simulations were used for structural analyses.
The orientational order parameter2SCD for each carbon of POPC’s palmi-
toyl and oleoyl chains was calculated from the angle q of the C-D bond rela-
tive to the bilayer normal (36):
2SCD ¼ 1
2

3cos2q 1: (2)
RESULTS
Calcein leakage and bilayer integrity
When TAM is introduced to calcein-encapsulated ULVs, its
large hydrophobicity prompts it to bind to surrounding
ULVs. The resulting membrane perturbation causes encap-
sulated calcein to leak out. By monitoring the change of
fluorescence intensity, one can estimate the amount of cal-
cein that is released. Fluorescence spectra of POPC/POPGBiophysical Journal 108(10) 2492–2501ULVs incubated with different amounts of TAM are shown
in Fig. S13. The emission maximum is located near 514 nm
and is independent of TAM concentration. The calculated
percentage of calcein leakage is shown in Fig. 1. It is clear
that the leakage percentage increases rapidly as the TAM/
lipid ratio, r, increases. Maximum leakage is reached near
r ¼ 1.0.
We use a Hill equation to qualitatively describe calcein
leakage:
Gðr; r0; n;FmaxÞ ¼ Gmax r
n
rn0 þ rn
; (3)
where Gmax is the maximum leakage, r is the TAM/lipid ra-
tio, r0 is the ratio at which the half-maximum of calcein
leakage occurs, and n is the Hill coefficient. We note that
the use of Eq. 3 is purely empirical. A nonlinear least-square
fit gives rise to a maximum leakage Gmax of 85%, a value
smaller than unity. This indicates that even at maximum
leakage, there is still a portion of calcein encapsulated
within the ULVs. Partial maximum leakage has also been re-
ported for flavanoid genistein and its derivatives (37), and
fibril-forming amyloid peptides (38). The fit to the data
also results in an r0 of 0.46 at half-maximum leakage, and
a Hill coefficient n of 1.5. Overall, our fluorescence data
highlight that TAM impairs bilayer integrity and enhances
the permeability of calcein across the bilayer. The fact
that the maximum leakage is less than 100% suggests that
TAM only modifies the structural properties of the lipid
bilayer. This is different from surfactants (39) and antimi-
crobial peptides (40), which solubilize or completely per-
meabilize lipid vesicles at high concentrations.FTIR spectroscopy and lipid bond vibrational
dynamics
To study the effect of TAM on lipid vibrational dynamics,
we performed attenuated total reflection FTIR
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centrations of TAM. Fig. 2 illustrates the absorption bands
corresponding to three chemical groups: the hydrocarbon
chain region (CH2, Fig. 2 A), the backbone ester carbonyl
(C¼O; Fig. 2 B), and the water-solvated headgroup (PO2;
Fig. 2 C). The spectrum for each sample is normalized by
its lipid concentration. This is corroborated by the nearly
identical absorption peaks located around 1229 and
1087 cm1, which correspond to PO2
’s antisymmetric
and symmetric vibrations, respectively (Fig. 2 C). No
discernible band shift is observed for the two bands corre-
sponding to the hydrocarbon chain CH2’s antisymmetric
(2923 cm1) and symmetric (2853 cm1) vibrations as
TAM concentration increases (Fig. 2 A). The absence of
band shift is also noted for the ester carbonyl C¼O
(Fig. 2 B). These results contrast with the FTIR measure-
ments obtained for TAM in fully saturated lipids
(10,13,14,16).
In contrast to the band shift, the band magnitudes for CH2
and C¼O decrease with increasing TAM concentration
(Fig. 2, A and B). Since the absorption spectrum is normal-
ized by the lipid concentration, the band magnitude is asso-
ciated with a change in the bond length (or dipole moment)
during bond vibration. Therefore, a reduction in the band
magnitude implies that TAM dampens the bond-length
change for CH2 and C¼O groups. This implies a more rigid
configuration in the hydrocarbon chains and carbonyl back-
bone region. In contrast to CH2 and C¼O, the vibrational
bands for PO2
 remain unaltered after addition of TAM
(Fig. 2 C), suggesting that TAM does not interact with
POPC’s phosphate headgroup.FIGURE 2 Attenuated total reflection FTIR spectrum for POPC MLVs
containing different concentrations of TAM. (A) Lipid IR absorption bands
located near 2923 and 2853 cm1 correspond to hydrocarbon chain CH2
groups undergoing antisymmetric and symmetric stretching vibrations,
respectively. (B) The absorption band of the backbone ester carbonyl
C¼O occurs near 1733 cm1. (C) Antisymmetric and symmetric absorption
bands corresponding to the phosphate PO2
 are observed near 1229 and
1087 cm1, respectively. The width of each panel is proportional to the
span of its wavenumber. To see this figure in color, go online.SANS data and bilayer thickness
Hydrogen and its isotope, deuterium, possess very
different neutron scattering lengths. This results in a large
difference in neutron scattering length density (NSLD) be-
tween the lipid bilayer’s protiated hydrocarbon chains and
the D2O water solvent. In this study, we collected SANS
data under three external contrast conditions (i.e., 100%,
75%, and 50% D2O) for POPC/POPG ULVs, with and
without 10 mol % TAM. We used a three-strip model
(Supporting Material) (41) to simultaneously analyze the
three sets of SANS data (Fig. 3). The corresponding struc-
tural parameters are listed in Table S1. At each D2O con-
centration, good overlap is observed between the model
and the experimental data. The resulting hydrocarbon
chain thickness of 24.6 A˚ is smaller by 4 A˚ compared
with previously determined POPC (42) and POPG (43) bi-
layers. For the headgroup thickness, an overestimation is
observed. This is consistent with a previous finding that
multi-strip models tend to overestimate the polar head-
group thickness (41), possibly due to an oversimplification
of the heterogeneous NSLD distribution within the head-
group region.
Addition of TAM increases the hydrocarbon chain thick-
ness of the lipid bilayer by 2.8 A˚. The observed chain
thickening is consistent with TAM’s rigidifying effect on
the lipid chain vibrational dynamics. Similar to what has
been reported for cholesterol (44,45), TAM’s triple-ring
structure could restrict the dynamics of nearby hydrocar-
bon chains, forcing them to adopt a more linear conforma-
tion and thus yielding a thicker bilayer. Note that our
SANS data reveal an overall change in the lipid bilayer
structure. An increase in hydrocarbon chain thickness
could simply be due to the addition of TAM without
altering the lipid properties. However, this was not the
case, as was revealed by our MD simulations (discussed
further below).FIGURE 3 Simultaneous three-strip model fits (solid lines) to SANS data
(open symbols) for POPC/POPGULVs at three external contrast conditions.
Intensities were shifted vertically for better visualization. Error bars at
small q are less than the dimensions of the symbols. To see this figure in
color, go online.
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FIGURE 4 Lipid bilayer area compressibility modulus KA obtained from
force-separation curves. (A) A typical force-separation curve for a solid
supported lipid bilayer. The increased force from 6 to 3 nm as the tip
approaches the substrate is predominantly contributed by tip indentation
into the lipid bilayer. The green line is a theoretical fit based on the bilayer
deformation model outlined in the main text. (B) KA at different TAM con-
centrations. The KAvalues for 0, 3, 5, and 10 mol % TAM are 278, 299, 348,
and 622 mN/m, respectively. The uncertainty of each KA is ~15%. The solid
line is a quadratic fit. To see this figure in color, go online.
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We used AFM-based force spectroscopy to explore lipid
bilayer mechanical properties. Based on the height profile
of a partially formed POPC/POPG bilayer (Supporting Ma-
terial), the bilayer surface protrudes by 6 nm above the mica
substrate. After a large bilayer patch is formed, as shown by
the topographic image, we collected force-distance curves
by monitoring the cantilever deflection d and the piezoelec-
tric distance z as the AFM tip approached and retracted from
the lipid bilayer. For the lipid bilayer, a jump near 5 nN was
observed in the approaching curve (Supporting Material).
When the tip is far from the bilayer, no resistance force ex-
ists. As the tip moves in the vicinity of the bilayer, vdW and
electrostatic interactions emerge. In the intermediate regime
where the tip makes contact but does not puncture the
bilayer, bilayer deformation becomes the predominant
source contributing to the tip force. In this regime, tip inden-
tation causes nearby lipid molecules to adopt a stretched
conformation. The free energy associated with the increased
lipid area under the curved tip can be described by the area
compressibility modulus KA (46). The relation between the
tip force F and the tip indentation z0 can be approximated as
F ¼ pKAR½z0=ðh z0Þ2; (4)
where R is the tip radius and h is the intact bilayer height. To
obtain the tip indentation, we convert the force-distance
curves into force-separation curves. The separation refers
to the distance between the tip apex and the mica substrate.
A force-separation curve is shown in Fig. 4 A. It is clear that
the bilayer deformation mainly takes place when the separa-
tion changes from 6 to 3 nm. It is interesting to note that
there is an ~3-nm-thick space between the substrate and
the point where the bilayer is punctured. This region corre-
sponds to a water layer cushioning the bilayer. Within the
bilayer elastic deformation regime, the tip indentation z0 is
the difference between the bilayer height and the tip-sub-
strate separation. The bilayer KA is obtained by fitting the
force-separation data using Eq. 4. An example of the data
fitting is shown in Fig. 4 B. Good agreement is obtained be-
tween the theoretical predication and the experimental data.
Note that we only include data points with separations of
<6 nm. Inclusion of data points at larger separations only
slightly changes KA. Another consideration is that Eq. 4 is
only valid in the bilayer deformation regime (i.e., the sepa-
ration should be no larger than the bilayer height). After an
analysis of >300 force curves, the averaged KA for the pure
lipid bilayer is 278 mN/m with an uncertainty of ~15%.
Our force-spectroscopy-derived KA is in good agreement
with results obtained from micropipette aspiration measure-
ments (47).
The same analyses were performed for force curves ob-
tained from bilayers with different amounts of TAM. The re-
sults are shown in Fig. 4 B. It is clear that KA increases with
TAM concentration. At 10 mol % TAM, the KA value isBiophysical Journal 108(10) 2492–2501doubled compared with that obtained for the pure lipid
bilayer. Similar to our findings with TAM, cholesterol was
previously observed to increase the KA of a POPC bilayer
(48). However, 30 mol % of cholesterol is needed to double
the KA. In contrast to the fused-ring system of cholesterol,
TAM contains an extended triple-ring structure, which
may contribute to the larger resistance under lateral
compression.MD simulations
We performed all-atom MD simulations of a POPC/POPG
bilayer before and after adding 10 mol % TAM. To assess
the effect of the initial configurations of TAM molecules
within the lipid bilayer, we built two TAM-lipid systems.
The initial tilt angles of the 20 TAM molecules are popu-
lated within a range of 7–38 in one leaflet, and 142–172
in the opposite leaflet (Supporting Material). Tilt angle is
defined by the vector O-C11 connecting the oxygen and
C11 atoms of TAM with respect to the bilayer normal
(Fig. 5 A). The time trajectories for the 20 TAM molecules
indicate that the individual tilt angles oscillate between 30
and 150, with a periodicity of ~20 ns (Supporting Mate-
rial), highlighting a highly dynamic conformation of TAM
within the lipid bilayer. To test the convergence of our
simulations, we calculated time-block averaged TAM
FIGURE 5 TAM orientation within the POPC/POPG bilayer. (A) Sche-
matic of a TAM molecule and the atoms used for orientation analysis.
Two vectors, C15-C19 and O-C11, are defined by the lines connecting
the corresponding atoms. (B–D) Snapshots of TAM molecules exhibiting
different orientations. To see this figure in color, go online.
FIGURE 6 Number density distributions for lipid components and the
tail nitrogen atom of TAM (N-TAM). (A) A POPC lipid molecule is parsed
into six components: G1, G2, and G3 for the headgroup, and CH, CH2, and
CH3 for the hydrocarbon chains. Selected carbon indices used for order
parameter calculations (Fig. 7) are indicated. (B) Atom-number averaged
number density distributions for the six lipid components depicted in A.
The number density distribution of N-TAM was normalized to match the
integral of lipid components. To see this figure in color, go online.
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120 ns block (from 80 ns to 120 ns) overlapped very well
with the 160 ns block (120–160 ns) with regard to both
orientation and position. Moreover, the two independent
sets of TAM-lipid simulations show similar distributions
and time-averaged structural parameters (Supporting Mate-
rial), supporting the convergence of our simulations.
A comparison between equilibrated bilayers, with and
without TAM, reveals that the addition of 10 mol % TAM
increases the hydrocarbon chain thickness 2DC by 0.8 A˚
(Supporting Material). This value is smaller than that deter-
mined from SANS data. However, the differences between
our simulation and SANS results are not surprising consid-
ering the simple model we used to analyze the SANS data.
Moreover, the 2DC values from our simulations match very
well with the actual bilayer hydrocarbon chain thicknesses
for POPC and POPG bilayers (22,49). Applying the princi-
ple that the total volume probability along the bilayer
normal equals unity (50), we determined the hydrocarbon
chain volume Vchain from our simulations. Using the box
relation that lipid area equals Vchain/DC, this gives rise to
a lipid area of 64.8 and 63.2 A˚2 for bilayers without and
with TAM, respectively. Overall, our simulation data indi-
cate that addition of TAM increases the lipid bilayer
hydrocarbon chain thickness (by 0.8 A˚) and consequently
decreases the lipid area (by 1.6 A˚2). These results are in
qualitative agreement with our SANS data.
The two vectors connecting the C15 and C19 atoms (C15-
C19), and the oxygen and C11 atoms (O-C11) of TAM
(Fig. 5 A) are used to describe TAM orientation in the lipid
bilayer. As mentioned above, the time trajectories show fastfluctuation dynamics of the TAM molecules (Supporting
Material). Snapshots of TAM molecules exhibiting different
conformations are shown in Fig. 5, B–D. TAM can reside at
the center of the bilayer or upright in the hydrocarbon chain
region. The time-averaged distributions of the two vectors,
with respect to the bilayer normal, are shown in Fig. S10.
Both vectors exhibit a broad distribution of a nearly equal
probability between ~30 and 150.
To visualize where TAM is located within the lipid
bilayer, we calculated atom-number averaged number den-
sity distributions for the six lipid components (Fig. 6 A)
and the tail nitrogen atom of TAM (N-TAM). The results
are shown in Fig. 6 B. Overall, the N-TAM atom resides
within the hydrocarbon chain region, with maximum prob-
abilities located at the bilayer center and near the glyc-
erol-carbonyl backbone. This observation is consistent
with the polar nature (basicity) of the tertiary amine group.
Similar to what has been observed for the hydroxyl group of
cholesterol, one favorable location for the hydrophilic nitro-
gen atom is near the backbone region. The water-amine in-
teractions are largely due to hydrogen bonding between the
proton in the water molecule and the lone electron pair on
the nitrogen atom. However, the hydrophilicity of the ter-
tiary amine group is not strong enough to keep TAM in
the backbone region, as revealed by time trajectories. The
second most favorable region for the nitrogen atom to reside
is at the bilayer center, where TAM preferentially assumes a
nearly horizontal orientation to minimize the interruption of
local lipid chain packing.Biophysical Journal 108(10) 2492–2501
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orientation of TAM within the lipid bilayer. The position
and orientation of TAM are represented by the z axis posi-
tion of the C11 atom and the tilt angle of the vector
O-C11 (with respect to the bilayer normal), respectively.
A clear correlation between the two parameters is observed
(Supporting Material). Specifically, for the z position
ranging from 5 to 10 A˚, the most probable tilt angles are be-
tween 20 and 90. As the C11 atom moves toward the
bilayer center, the most probable angles are confined to a re-
gion near 90. This observation echoes the notion that TAM
exhibits different orientations depending on where it is
located.
We also calculated the orientational order parameter
2SCD for each carbon atom in POPC chains (51). The re-
sults are shown in Fig. 7. The carbon indices for each chain
are indicated in Fig. 6 A. For the palmitoyl chain, a slight
increase is observed for carbon numbers 4–10. A similar in-
crease is observed for the monounsaturated oleoyl chain,
mainly for carbon numbers 4–9. For carbon atoms located
near the bilayer center, no ordering is observed. The aver-
aged order parameters for POPC chain carbons are 0.141
(without TAM) and 0.144 (with TAM)—an overall 2% in-
crease. This is a rather small change compared with that
induced by cholesterol, which orients upright and increases
lipid chain order parameters by a significant amount (52).
The small increase of the lipid chain order parameters by
TAM is consistent with the small increase in 2DC.DISCUSSION
Cell membranes are important targets for many drugs (53).
Elucidating the molecular interactions that occur between
lipid model membranes and administered drugs will aid in
the development of more effective drugs. Here, we studied
the interactions of TAM with a model lipid membrane.
Time-course fluorescence measurements revealed a two-
phase leakage behavior. This can be explained by TAM first
binding to the outer leaflet of ULVs. The subsequent asym-FIGURE 7 Order parameters2SCD for POPC chains obtained fromMD
simulations of a POPC/POPG bilayer before (open symbols) and after (solid
symbols) the addition of 10 mol % TAM. (A) Palmitoyl chain. (B) Oleoyl
chain. To see this figure in color, go online.
Biophysical Journal 108(10) 2492–2501metric distribution of TAM between the inner and outer leaf-
lets stresses the bilayer, causing calcein to leak out at a fast
rate from the vesicle interior. After some time, TAM gradu-
ally transverses into the inner leaflet through a slow process,
such as flip-flop (54). This accounts for the slow leakage
phase. Engelk et al. (11) also observed TAM-induced dye
leakage using a lipid mixture composed of egg-PC, choles-
terol, and a-tocopherol, but did not identify any two-phase
leakage behavior. Moreover, the authors observed that
5 mol % TAM induced 80% dye leakage after only
50 min of incubation. These differences may highlight the
role of lipids in modulating TAM activity.
High-resolution AFM has emerged as an invaluable tool
for exploring membrane nanomechanics. Our AFM-based
force spectroscopy measurements indicate that the KA is
doubled in the presence of 10 mol % TAM. It is known
that membrane proteins are sensitive to the force from lipids
(55). Modulating the mechanical properties of the mem-
brane may be a means by which TAM controls protein func-
tions. One problem in cancer treatment is drug efflux caused
by multidrug resistant transporters. TAM has been found to
effectively reverse multidrug resistance in several cancer
cell lines (56). Altering the membrane’s mechanical proper-
ties offers a new way to explore transporter inhibition
by TAM.
We examined atomic-level interactions between TAM
and lipid bilayers in MD simulations. In particular, the addi-
tion of TAM increased hydrocarbon chain thickness by
0.8 A˚ and decreased the average lipid area by 1.6 A˚2. The
small changes of these two parameters are consistent with
lipid chain order parameter calculations. The structural pa-
rameters obtained from our simulations are in qualitative
agreement with the bilayer thickening shown by SANS
data and the reduced lipid bond vibrational dynamics re-
vealed by FTIR measurements. It is worth noting that both
our SANS measurements and MD simulations indicate
that TAM increases lipid bilayer thickness. However, no
discernible band shift was observed in the FTIR spectra.
This suggests that band shift is not a good criterion for de-
tecting small changes in bilayer thickness.
Our orientational order parameter calculations indicate
that lipid chain carbons located near the backbone are
more susceptible to ordering by TAM. The reduced influ-
ence on lipid chain order toward the bilayer center has
also been observed for a voltage sensor toxin (57). This
observation can be explained by considering the orientation
of TAM’s triple-ring structure. Our 2D probability calcula-
tions indicate that the ring structure has a tilt angle range
of 20–90 when it is near the backbone and 80–120 when
it is near the bilayer center (Supporting Material). Since
the largest ordering effect occurs when the ring structure
is parallel to the chain direction, the upper chain carbons
are more susceptible to ordering by the ring structure of
TAM than those near the bilayer center. In addition, the cen-
tral carbons are likely to be disordered by the bulky ring
Tamoxifen Interacting with Lipid Membranes 2499structure, which adopts a nearly parallel orientation when
residing at the bilayer center.
Our simulation data show that TAM does not have a pref-
erence for associating with either POPC or POPG (Support-
ing Material). This is understandable because TAM
molecules are located in the hydrocarbon chain region,
and POPC and POPG have the same chain composition.
More importantly, we find that TAM can reside either at
the bilayer center or upright in the hydrocarbon chain re-
gion. The main TAM axis displays a broad angular distribu-
tion. Similarly, the nitrogen atom is broadly distributed
within the hydrocarbon chain region, with its maximum
probability located at the bilayer center or near the back-
bone. TAM’s fast conformational dynamics within the lipid
bilayer may be beneficial when rapid recognition of TAM by
the binding pockets of estrogen receptors is required.
It is well known that the permeability of small solutes is
inversely related to the hydrocarbon chain thickness and
proportionally related to the free fraction of the lipid area
(58). Indeed, an increasing cholesterol content leads to a
thicker bilayer with a lower water permeability (59). This
is in drastic contrast to TAM, which thickens the lipid
bilayer but enhances the calcein permeability. Therefore,
factors other than the lipid bilayer thickness should be
responsible for increasing the solute permeability in the
presence of TAM. It is conceivable that the highly dynamic
conformation of TAM could induce transient defects to
allow solutes to translocate across the bilayer.CONCLUSIONS
We studied the effects of the anticancer drug TAM on a
model membrane’s permeability, bond vibrational dy-
namics, bilayer thickness, and bilayer nanomechanics, as
well as its interactions with surrounding lipids, using a num-
ber of experimental and computational techniques,
including fluorescence dye leakage, FTIR spectroscopy,
SANS measurements, AFM-based force spectroscopy, and
all-atom MD simulations. We found that TAM impairs lipid
bilayer integrity, causing calcein molecules to leak from the
interior of lipid vesicles. FTIR spectroscopy shows that
TAM suppresses bond vibrational dynamics located in the
hydrocarbon chain region. TAM also increases bilayer hy-
drocarbon chain thickness, as revealed by our SANS data
and MD simulations. AFM-based force spectroscopy mea-
surements show that TAM increases the lipid bilayer area
compressibility modulus by a large amount. Detailed ana-
lyses of our MD simulation data show that: 1) the orienta-
tion of TAM oscillates between 30 and 150 with respect
to the bilayer normal; 2) TAM can reside at any depth within
the hydrocarbon chain region; 3) TAM’s orientation varies
as a function of its depth within the bilayer; and 4) TAM’s
hydrophilic tertiary amine group preferentially locates
either at the bilayer center or at the headgroup-chain inter-
face. The various experimental and computational resultsobtained from our studies should prove useful for illus-
trating TAM’s effects on lipid membranes.SUPPORTING MATERIAL
Thirteen figures and two tables are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(15)00388-4.AUTHOR CONTRIBUTIONS
J.P. and X.C. designed the project. N.K.K., C.S.H., and J.P. performed the
experiments and analyzed the experimental data. X.C. performed the MD
simulations and analyzed the simulation data. X.C., J.K., and J.P. wrote
the manuscript.ACKNOWLEDGMENTS
We thank Dr. Frederick A. Heberle for help with sample preparation and
data collection for the SANS experiments. We also thank Dr. Martin Mu-
schol and Ms Tatiana Miti for help with osmotic pressure measurements.
J.P. is supported through a startup package from the University of South
Florida. X.C. is partially supported by the Laboratory Directed R&D
(LDRD) program at Oak Ridge National Laboratory. J.K. is supported
through the Department of Energy (DOE) Scientific User Facilities Divi-
sion, Office of Basic Energy Sciences. This work received additional sup-
port from the DOE Office of Biological and Environmental Research for
the BioSANS instrument at the ORNL Center for Structural Molecular
Biology. This research used resources of the National Energy Research Sci-
entific Computing Center, a DOE Office of Science User Facility supported
by the Office of Science of the U.S. Department of Energy under contract
No. DE-AC02-05CH11231.REFERENCES
1. Clarke, M., R. Collins, ., E. B. C. T. C. Grp. 1998. Tamoxifen for
early breast cancer: an overview of the randomised trials. Early Breast
Cancer Trialists’ Collaborative Group. Lancet. 351:1451–1467.
2. Wiseman, H. 1994. Tamoxifen: new membrane-mediated mechanisms
of action and therapeutic advances. Trends Pharmacol. Sci. 15:83–89.
3. Shiau, A. K., D. Barstad,., G. L. Greene. 1998. The structural basis of
estrogen receptor/coactivator recognition and the antagonism of this
interaction by tamoxifen. Cell. 95:927–937.
4. Yang, L. H., H. S. Tseng, ., D. R. Chen. 2012. Survival benefit of
tamoxifen in estrogen receptor-negative and progesterone receptor-
positive low grade breast cancer patients. J. Breast Cancer. 15:
288–295.
5. O’Brian, C. A., R. M. Liskamp,., I. B. Weinstein. 1985. Inhibition of
protein kinase C by tamoxifen. Cancer Res. 45:2462–2465.
6. Ribeiro, M. P. C., A. E. Santos, and J. B. A. Custo´dio. 2014. Mitochon-
dria: the gateway for tamoxifen-induced liver injury. Toxicology.
323:10–18.
7. Custo´dio, J. B. A., L. M. Almeida, and V. M. C. Madeira. 1991. A reli-
able and rapid procedure to estimate drug partitioning in bio-
membranes. Biochem. Biophys. Res. Commun. 176:1079–1085.
8. Baum, M. 2002. Has tamoxifen had its day? Breast Cancer Res.
4:213–217.
9. Custo´dio, J. B. A., L. M. Almeida, and V. M. C. Madeira. 1993. The
anticancer drug tamoxifen induces changes in the physical properties
of model and native membranes. Biochim. Biophys. Acta. 1150:
123–129.Biophysical Journal 108(10) 2492–2501
2500 Khadka et al.10. Dicko, A., M. Morissette,., T. Di Paolo. 1999. Effect of estradiol and
tamoxifen on brain membranes: investigation by infrared and fluores-
cence spectroscopy. Brain Res. Bull. 49:401–405.
11. Engelk, M., P. Bojarski, ., H. Diehl. 2001. Tamoxifen perturbs lipid
bilayer order and permeability: comparison of DSC, fluorescence
anisotropy, laurdan generalized polarization and carboxyfluorescein
leakage studies. Biophys. Chem. 90:157–173.
12. Kazanci, N., and F. Severcan. 2007. Concentration dependent different
action of tamoxifen on membrane fluidity. Biosci. Rep. 27:247–255.
13. Bilge, D., I. Sahin, ., F. Severcan. 2014. Interactions of tamoxifen
with distearoyl phosphatidylcholine multilamellar vesicles: FTIR
and DSC studies. Spectrochim. Acta A Mol. Biomol. Spectrosc. 130:
250–256.
14. Bilge, D., N. Kazanci, and F. Severcan. 2013. Acyl chain length and
charge effect on tamoxifen-lipid model membrane interactions.
J. Mol. Struct. 1040:75–82.
15. Boyar, H., and F. Severcan. 1997. Tamoxifen-model membrane interac-
tions: an FT-IR study. J. Mol. Struct. 408:265–268.
16. Severcan, F., N. Kazanci, and F. Zorlu. 2000. Tamoxifen increases
membrane fluidity at high concentrations. Biosci. Rep. 20:177–184.
17. Wiseman, H., P. Quinn, and B. Halliwell. 1993. Tamoxifen and related
compounds decrease membrane fluidity in liposomes. Mechanism for
the antioxidant action of tamoxifen and relevance to its anticancer
and cardioprotective actions? FEBS Lett. 330:53–56.
18. Luxo, C., A. S. Jurado,., V. M. Madeira. 1996. Use of Bacillus stear-
othermophilus as a model to study tamoxifen-membrane interactions.
Toxicol. In Vitro. 10:463–471.
19. Suwalsky, M., P. Herna´ndez,., C. P. Sotomayor. 1998. Interaction of
the anticancer drug tamoxifen with the human erythrocyte membrane
and molecular models. Z. Naturforsch. C. 53:182–190.
20. Ayuyan, A. G., and F. S. Cohen. 2006. Lipid peroxides promote large
rafts: effects of excitation of probes in fluorescence microscopy and
electrochemical reactions during vesicle formation. Biophys. J. 91:
2172–2183.
21. Mannock, D. A., R. N. A. H. Lewis, and R. N. McElhaney. 2010. A
calorimetric and spectroscopic comparison of the effects of ergosterol
and cholesterol on the thermotropic phase behavior and organization of
dipalmitoylphosphatidylcholine bilayer membranes. Biochim. Biophys.
Acta. 1798:376–388.
22. Kucerka, N., J. F. Nagle,., J. Katsaras. 2008. Lipid bilayer structure
determined by the simultaneous analysis of neutron and X-ray scat-
tering data. Biophys. J. 95:2356–2367.
23. Hutter, J. L., and J. Bechhoefer. 1993. Calibration of atomic-force mi-
croscope tips. Rev. Sci. Instrum. 64:1868–1873.
24. Jo, S., J. B. Lim,., W. Im. 2009. CHARMM-GUI Membrane Builder
for mixed bilayers and its application to yeast membranes. Biophys. J.
97:50–58.
25. Martı´nez, L., R. Andrade, ., J. M. Martı´nez. 2009. PACKMOL: a
package for building initial configurations for molecular dynamics sim-
ulations. J. Comput. Chem. 30:2157–2164.
26. Phillips, J. C., R. Braun,., K. Schulten. 2005. Scalable molecular dy-
namics with NAMD. J. Comput. Chem. 26:1781–1802.
27. Klauda, J. B., R. M. Venable, ., R. W. Pastor. 2010. Update of the
CHARMM all-atom additive force field for lipids: validation on six
lipid types. J. Phys. Chem. B. 114:7830–7843.
28. Feller, S. E., D. Yin, ., A. D. MacKerell, Jr. 1997. Molecular dy-
namics simulation of unsaturated lipid bilayers at low hydration:
parameterization and comparison with diffraction studies. Biophys. J.
73:2269–2279.
29. Vanommeslaeghe, K., E. Hatcher, ., A. D. Mackerell, Jr. 2010.
CHARMM general force field: a force field for drug-like molecules
compatible with the CHARMM all-atom additive biological force
fields. J. Comput. Chem. 31:671–690.
30. Martyna, G. J., D. J. Tobias, and M. L. Klein. 1994. Constant pressure
molecular dynamics algorithms. J. Chem. Phys. 101:4177–4189.Biophysical Journal 108(10) 2492–250131. Feller, S. E., Y. H. Zhang, ., B. R. Brooks. 1995. Constant pressure
molecular dynamics simulation: the Langevin piston method.
J. Chem. Phys. 103:4613–4621.
32. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald: an
N.Log(N) method for Ewald sums in large systems. J. Chem. Phys.
98:10089–10092.
33. Essmann, U., L. Perera, ., L. G. Pedersen. 1995. A smooth particle
mesh Ewald method. J. Chem. Phys. 103:8577–8593.
34. Tuckerman, M., B. J. Berne, and G. J. Martyna. 1992. Reversible mul-
tiple time scale molecular-dynamics. J. Chem. Phys. 97:1990–2001.
35. Ryckaert, J. P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical
integration of the Cartesian equations of motion of a system with con-
straints: molecular dynamics of n-alkanes. J. Comput. Phys. 23:
327–341.
36. Seelig, A., and J. Seelig. 1974. The dynamic structure of fatty acyl
chains in a phospholipid bilayer measured by deuteriummagnetic reso-
nance. Biochemistry. 13:4839–4845.
37. Sroda, K., K. Michalak, ., A. B. Hendrich. 2008. Genistein deriva-
tives decrease liposome membrane integrity—calcein release and mo-
lecular modeling study. Biophys. Chem. 138:78–82.
38. Sheynis, T., A. Friediger,., R. Jelinek. 2013. Aggregation modulators
interfere with membrane interactions of b2-microglobulin fibrils.
Biophys. J. 105:745–755.
39. Heerklotz, H., and J. Seelig. 2007. Leakage and lysis of lipidmembranes
induced by the lipopeptide surfactin. Eur. Biophys. J. 36:305–314.
40. Ladokhin, A. S., W. C. Wimley, and S. H. White. 1995. Leakage of
membrane vesicle contents: determination of mechanism using fluores-
cence requenching. Biophys. J. 69:1964–1971.
41. Pencer, J., S. Krueger,., J. Katsaras. 2006. Method of separated form
factors for polydisperse vesicles. J. Appl. Cryst. 39:293–303.
42. Kucerka, N., M. P. Nieh, and J. Katsaras. 2011. Fluid phase lipid areas
and bilayer thicknesses of commonly used phosphatidylcholines as a
function of temperature. Biochim. Biophys. Acta. 1808:2761–2771.
43. Kucerka, N., B. W. Holland, ., J. Katsaras. 2012. Scattering density
profile model of POPG bilayers as determined by molecular dynamics
simulations and small-angle neutron and X-ray scattering experiments.
J. Phys. Chem. B. 116:232–239.
44. Hung, W. C., M. T. Lee,., H. W. Huang. 2007. The condensing effect
of cholesterol in lipid bilayers. Biophys. J. 92:3960–3967.
45. Pan, J., T. T. Mills,., J. F. Nagle. 2008. Cholesterol perturbs lipid bi-
layers nonuniversally. Phys. Rev. Lett. 100:198103.
46. Das, C., K. H. Sheikh,., S. D. Connell. 2010. Nanoscale mechanical
probing of supported lipid bilayers with atomic force microscopy.
Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 82:041920.
47. Rawicz, W., K. C. Olbrich,., E. Evans. 2000. Effect of chain length
and unsaturation on elasticity of lipid bilayers. Biophys. J. 79:328–339.
48. Evans, E., W. Rawicz, and B. A. Smith. 2013. Back to the future: me-
chanics and thermodynamics of lipid biomembranes. Faraday Discuss.
161:591–611.
49. Pan, J., D. Marquardt, ., J. Katsaras. 2014. Revisiting the bilayer
structures of fluid phase phosphatidylglycerol lipids: Accounting for
exchangeable hydrogens. Biochim. Biophys. Acta. 1838:2966–2969.
50. Petrache, H. I., S. E. Feller, and J. F. Nagle. 1997. Determination of
component volumes of lipid bilayers from simulations. Biophys. J.
72:2237–2242.
51. Berger, O., O. Edholm, and F. Ja¨hnig. 1997. Molecular dynamics sim-
ulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hy-
dration, constant pressure, and constant temperature. Biophys. J.
72:2002–2013.
52. Sodt, A. J., M. L. Sandar,., E. Lyman. 2014. The molecular structure
of the liquid-ordered phase of lipid bilayers. J. Am. Chem. Soc.
136:725–732.
53. Hendrich, A. B., and K. Michalak. 2003. Lipids as a target for drugs
modulating multidrug resistance of cancer cells. Curr. Drug Targets.
4:23–30.
Tamoxifen Interacting with Lipid Membranes 250154. Kornberg, R. D., and H. M. McConnell. 1971. Inside-outside transi-
tions of phospholipids in vesicle membranes. Biochemistry. 10:1111–
1120.
55. McIntosh, T. J., and S. A. Simon. 2006. Roles of bilayer material prop-
erties in function and distribution of membrane proteins. Annu. Rev.
Biophys. Biomol. Struct. 35:177–198.
56. Ramu, A., D. Glaubiger, and Z. Fuks. 1984. Reversal of acquired resis-
tance to doxorubicin in P388 murine leukemia cells by tamoxifen and
other triparanol analogues. Cancer Res. 44:4392–4395.57. Mihailescu, M., D. Krepkiy,., S. White. 2014. Structural interactions
of a voltage sensor toxin with lipid membranes. Proc. Natl. Acad. Sci.
USA. 111:E5463–E5470.
58. Nagle, J. F., J. C. Mathai, ., S. Tristram-Nagle. 2008. Theory of
passive permeability through lipid bilayers. J. Gen. Physiol. 131:
77–85.
59. Rawicz, W., B. A. Smith,., E. Evans. 2008. Elasticity, strength, and
water permeability of bilayers that contain raft microdomain-forming
lipids. Biophys. J. 94:4725–4736.Biophysical Journal 108(10) 2492–2501
